Skip to content
★ Sign in to follow
NG

Nancy G. Brown

Athenahealth Inc
Total declarations
71
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (68 ops.)
€4.2M

Latest filing published 02 Apr 2010 for ATHENAHEALTH INC.

Insider track record

Disclosed buys
0
Disclosed sells
68
Signal history

No signal scores available.

Nancy G. Brown: trading record in brief

Nancy G. Brown discloses dealings in Athenahealth Inc to SEC (Form 4). Between 2 May 2008 and 1 April 2010, the trades on record add up to 71 filings.

No open-market purchase appears, only 68 sales worth €4.2M. Besides market trades, the filings include 1 share grant and 2 option exercises. So far in 2010, the count stands at no purchases and 1 sale.

The latest filing, published on 2 April 2010, reports a share grant in Athenahealth Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Nancy G. Brown

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations70 total
  • ◆
    SVP, Corporate DevelopmentExecutivesAthenahealth Inc
    0SEC
    10,000 shares0Common StockSEC:0001209191-10-020117:0
  • ◇
    SVP, Corporate DevelopmentExecutivesAthenahealth Inc
    13,856 USD0SEC
    1,875 shares@ US$7.39Common StockSEC:0001209191-10-009019:0
  • ▼
    SVP, Corporate DevelopmentExecutivesAthenahealth Inc
    73,744 USD0SEC
    1,875 shares@ US$39.33Common StockSEC:0001209191-10-009019:1
  • ◇
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    27,713 USD0SEC
    3,750 shares@ US$7.39Common StockSEC:0001209191-09-051918:0
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    12,540 USD0SEC
    300 shares@ US$41.80Common StockSEC:0001209191-09-051918:1
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    26,578 USD0SEC
    636 shares@ US$41.79Common StockSEC:0001209191-09-051918:2
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    4,177 USD0SEC
    100 shares@ US$41.77Common StockSEC:0001209191-09-051918:3
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    42,345 USD0SEC
    1,014 shares@ US$41.76Common StockSEC:0001209191-09-051918:4
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    14,906 USD0SEC
    356 shares@ US$41.87Common StockSEC:0001209191-09-051918:5
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    4,188 USD0SEC
    100 shares@ US$41.88Common StockSEC:0001209191-09-051918:6
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    16,740 USD0SEC
    400 shares@ US$41.85Common StockSEC:0001209191-09-051918:7
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    29,288 USD0SEC
    700 shares@ US$41.84Common StockSEC:0001209191-09-051918:8
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    1,841 USD0SEC
    44 shares@ US$41.83Common StockSEC:0001209191-09-051918:9
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    4,181 USD0SEC
    100 shares@ US$41.81Common StockSEC:0001209191-09-051918:10
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    154,605 USD0SEC
    5,500 shares@ US$28.11Common StockSEC:0001209191-08-064861:0
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    133,676 USD0SEC
    4,600 shares@ US$29.06Common StockSEC:0001209191-08-064861:1
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    177,708 USD0SEC
    5,900 shares@ US$30.12Common StockSEC:0001209191-08-064861:2
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    30,264 USD0SEC
    1,200 shares@ US$25.22Common StockSEC:0001209191-08-063220:0
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    49,973 USD0SEC
    1,925 shares@ US$25.96Common StockSEC:0001209191-08-063220:1
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    134,650 USD0SEC
    5,000 shares@ US$26.93Common StockSEC:0001209191-08-063220:2
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    134,400 USD0SEC
    5,000 shares@ US$26.88Common StockSEC:0001209191-08-061302:0
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    80,094 USD0SEC
    3,125 shares@ US$25.63Common StockSEC:0001209191-08-060769:0
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    23,080 USD0SEC
    800 shares@ US$28.85Common StockSEC:0001209191-08-058786:0
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    125,622 USD0SEC
    4,200 shares@ US$29.91Common StockSEC:0001209191-08-058786:1
  • ▼
    SVP, Business DevelopmentExecutivesAthenahealth Inc
    75,600 USD0SEC
    2,800 shares@ US$27.00Common StockSEC:0001209191-08-058146:0

25 of 70 declarations